Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
03/2009
03/12/2009WO2009033033A2 Compositions of kinase inhibitors and their use for treatment of cancer and other diseases related to kinases
03/12/2009WO2009032668A2 2 -biphenylamino-4 -aminopyrimidine derivatives as kinase inhibitors
03/12/2009WO2009032667A1 Thiazole and oxazole kinase inhibitors
03/12/2009WO2009032277A1 Gamma secretase modulators
03/12/2009WO2009031709A1 Coumarin compound and use thereof
03/12/2009WO2009030968A1 Mao a inhibitors with a diphenyl ether-substructure.
03/12/2009WO2009030952A2 Phenylcarboxamide derivatives as inhibitors and effectors of the hedgehog pathway
03/12/2009WO2009030333A1 Thiadiazinone derivatives
03/12/2009WO2009030316A1 1,3-dihydroisoindole derivatives
03/12/2009WO2009029998A1 Retrometabolic compounds
03/12/2009WO2009010871A3 Pyrazole derivatives as antagonists of adenosine a3 receptor
03/12/2009WO2009010478A8 Use of piperidine derivatives as agonists of chemokine receptor activity
03/12/2009WO2009010139A3 Quinazolinamide derivatives
03/12/2009WO2009007415A3 Novel compounds
03/12/2009WO2009003672A3 Novel microbiocides
03/12/2009WO2008132600A3 Trpv1 antagonists and uses thereof
03/12/2009WO2008035305A8 Pyridine derivatives for the treatment of metabolic disorders related to insulin resistance or hyperglycemia
03/12/2009WO2007092681A3 Piperidinyl derivatives as modulators of chemokine receptor activity
03/12/2009US20090069565 New indole derivatives as factor xa inhibitors
03/12/2009US20090069385 Antidiabetic Oxazolidinediones and Thiazolidinediones
03/12/2009US20090069383 Thrombin Receptor Antagonists
03/12/2009US20090069322 N-formyl hydroxylamine derivatives as inhibitors of bacterial polypeptide formylase for treating microbial infections
03/12/2009US20090069316 Novel quinoline derivatives
03/12/2009US20090069311 histamine H3-antagonists such as [5-(1-ethyl-piperidin-4-ylamino)-1H-indol-2-yl]-piperidin-1-yl-methanone, used for the treatment of obesity or eating disorders, and non-insulin dependent diabetes
03/12/2009US20090069310 Anti-inflammatory medicaments
03/12/2009US20090069298 Pyrazolo[1,5-A]Pyrimidine Compounds
03/12/2009US20090069252 C-glycoside derivatives and salts thereof
03/12/2009US20090068699 Use of glutaminyl cyclase inhibitors
03/12/2009US20090066245 Material for light-emitting element and light emitting element
03/12/2009CA2698341A1 Gamma secretase modulators
03/12/2009CA2698062A1 Thiadiazinone derivatives
03/12/2009CA2697934A1 1,3-dihydroisoindole derivatives
03/12/2009CA2696824A1 Compounds and compositions as kinase inhibitors
03/12/2009CA2684037A1 Compounds with anti-cancer activity
03/11/2009EP2033954A1 6-(heterocycle-substituted benzyl)-4-oxoquinoline compound and use of the same as hiv integrase inhibitor
03/11/2009EP2033953A1 Vanilloid receptor modulators
03/11/2009EP2033952A1 Nitrogen-containing Heteroaryl compounds having HIV Integrase Inhibitory Activity
03/11/2009EP2033951A2 2-Piperazine-pyridines useful for treating pain
03/11/2009EP2033637A1 Therapeutic or prophylactic agent for leukemia
03/11/2009EP2032570A1 Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
03/11/2009EP2032569A1 Process for the synthesis of benzylidene rosiglitazone base
03/11/2009EP2032566A1 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
03/11/2009EP2032562A2 Selective inhibitors of rock protein kinase and uses thereof
03/11/2009EP2032548A1 Thiazole derivatives
03/11/2009EP2032543A1 2-anilino-4-aminoalkyleneaminopyrimidines
03/11/2009EP2032542A2 Heterocyclic aspartyl protease inhibitors
03/11/2009EP1879580B1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
03/11/2009EP1753758B1 Mercaptoimidazoles as ccr2 receptor antagonists
03/11/2009EP1656374B1 Thiazole derivatives as npy antagonists
03/11/2009EP1581526B1 Benzisoxazole derivatives useful as inhibitors of protein kinases
03/11/2009EP1349840B1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
03/11/2009EP1317445B1 Chemokine receptor binding heterocyclic compounds
03/11/2009EP1175399B1 Inhibitors of c-jun n-terminal kinases (jnk)
03/11/2009CN101384587A Heterocyclic antiviral compounds
03/11/2009CN101384586A Pi-3 kinase inhibitors and methods of their use
03/11/2009CN101384583A Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
03/11/2009CN101384581A Benzoyl-piperidine derivatives as 5HT2/D3 modulators
03/11/2009CN101384568A Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
03/11/2009CN101384554A Pyridine-2-carboxamide derivatives
03/11/2009CN101381367A 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, maleic acid salt, hydrate as pharmaceutical
03/11/2009CN101381361A Organic compound for recording layer and optical recording medium including the same
03/11/2009CN101381342A Piperazine derivatives and applications thereof
03/11/2009CN101380319A Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
03/11/2009CN100466924C Corrective clothes with liner
03/10/2009US7501516 3-Cyanoquinolines 4-substituted by a methylenedioxyphenyl group that is attached by a methylene, oxy, thio, sulfinyl, sulfonyl or amino group; antitumor agents
03/10/2009US7501445 Imidazolidinone compounds
03/10/2009US7501427 Such as N6-(4,5-dihydrooxazol-2-yl)-N4-[3-methyl-4-(6-methylpyridin-3-yloxy)-phenyl]-quinazoline-4,6-diamine; for treatment of hyperproliferative disorders such as cancer
03/10/2009US7501418 e.g. 3-[4-(2-Methyl-3-phenyl-allyl)-piperazin-1-ylmethyl]-3a,4-dihydro-3H-2,5-dioxa-1,7-diaza-dicyclopenta[a,g]naphthalene; serotonine (5-HT) reuptake inhibitor, alpha 2-adrenoceptor antagonist; antidepressant, anxiolytic agent; Parkinson's disease, eating disorders, psychosis, obesity
03/10/2009US7501416 Quinoxaline compounds and methods of using them
03/10/2009US7501414 Substituted morpholine and thiomorpholine derivatives
03/10/2009US7501408 2-(R)-Cyclohexylmethyl-N-[1-(S)-methyl-2-(4-trifluoromethoxy-phenylamino)-ethyl]-4-oxo-4-thiomorpholin-4-yl-butyramide; selective in presence of at least one other cathepsin isozyme; antiinflammatory agent: arthritis, atherosclerosis
03/10/2009US7501407 Amide substituted pyrimidine compound; antiarthritic agents; antiischemic agents; antidiabetic agents; inflammatory bowel disease; antiproliferative agents; antiallergens
03/10/2009CA2377233C Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof
03/10/2009CA2368418C 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders
03/10/2009CA2342210C Thiazoline acid derivatives
03/05/2009WO2009029214A1 Isoquinolone derivatives as phosphodiesterase 10 inhibitors
03/05/2009WO2009028543A1 Substituted pyrazole derivative
03/05/2009WO2009027746A1 Heterocyclic amides useful for the treatment of cancer and psoriasis
03/05/2009WO2009027475A1 Phenylisoquinoline and phenylquinazoline derivatives for the treatment of bone diseases
03/05/2009WO2009027392A1 4-(4-pyridinyl)-benzamides and their use as rock activity modulators
03/05/2009WO2009026701A1 Sirtuin inhibitors
03/05/2009WO2009012242A3 Sodium channel inhibitors
03/05/2009WO2009010455A3 Pyrazole derivatives as modulators of metabotropic glutamate receptors
03/05/2009WO2009005690A3 Antiviral compounds
03/05/2009WO2009005677A3 Antiviral compounds
03/05/2009WO2009005676A3 Antiviral compounds
03/05/2009WO2008151828A3 Novel microbiocides
03/05/2009WO2008147557A3 Heteroaryl substituted thiazoles and their use as antiviral agents
03/05/2009WO2008138591A3 Bicyclic and heterobicyclic derivatives,processes for preparing them and their uses
03/05/2009WO2008137622A3 Aminopyrimidines useful as kinase inhibitors
03/05/2009WO2008070447A3 Anti-viral compounds
03/05/2009US20090062531 Arylacetate Derivatives Having Isoxazole Skeleton
03/05/2009US20090062530 Substituted arylalkanoic acid derivatives and use thereof
03/05/2009US20090062358 Peroxisome proliferator activated receptor alpha agonists
03/05/2009US20090062307 aminopyrazine derivatives; ROCK inhibitors; 3-(1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl)pyrazin-2-amine; antiinflammatory, antidiabetic, antiproliferative agents
03/05/2009US20090062303 Deuterium-enriched ziprasidone
03/05/2009US20090062293 1,4-Substituted Piperazine Derivatives
03/05/2009US20090062267 L-ALANINE DERIVATIVES AS a5beta1 ANTAGONISTS
03/05/2009US20090062266 7-methoxy-2-methyl-N-[[(5S)-[3-[3-fluoro-4-(piperazin-1-yl)phenyl]-2-oxo-5-oxazolidinylmethyl]-3-quinolinecarboxamide, useful for the treatment of grampositive and some gramnegative bacterial infections, with a weak monoamine oxidase inhibitory activity
03/05/2009US20090062259 Bezothiazol Derivatives as Beta2 Adrenoreceptor Agonists